Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-02-22 @ 12:23 PM
Study NCT ID:
NCT04023669
Status:
COMPLETED
Last Update Posted:
2025-02-07
First Post:
2019-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
Sponsor:
St. Jude Children's Research Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Brain Tumor | View |
| None | Brain Tumor, Recurrent | View |
| None | Brain Tumor, Refractory | View |
| None | Brain Tumor, Pediatric | View |
| None | Medulloblastoma | View |
| None | Medulloblastoma Recurrent | View |
| None | Medulloblastoma, Non-WNT/Non-SHH | View |
| None | Medulloblastoma, Non-WNT/Non-SHH, Group 3 | View |
| None | Medulloblastoma, Non-WNT/Non-SHH, Group 4 | View |
| None | Brain Cancer | View |
| None | CNS Cancer | View |
| None | CNS Tumor | View |
| None | CNS Neoplasm | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Brain Tumors in Adolescents | View |
| None | Brain Tumors in Children | View |
| None | Brain Tumors in Young Adults | View |
| None | CHK1/2 Inhibitor | View |
| None | Combination therapy | View |
| None | Indeterminate molecular subgroup | View |
| None | Medulloblastoma, Group 3 | View |
| None | Medulloblastoma, Group 4 | View |
| None | Medulloblastoma, G3/G4 | View |
| None | Progressive brain tumor | View |
| None | Recurrent brain tumor | View |
| None | Refractory brain tumor | View |
| None | Sonic hedgehog | View |
| None | SHH Medulloblastoma | View |
| None | St. Jude Brain Tumor Studies | View |
| None | St. Jude Studies | View |
| None | St. Jude Treatment | View |
| None | Molecular | View |
| None | Molecular therapy | View |